Now loading...
JM Financial has recommended a buy call on Sun Pharmaceutical Industries with a target price of Rs 2115, expecting a significant price increase from the current Rs 1655.2 over one year. Sun Pharma reported a consolidated total income of Rs 14141.08 crore for Q3 FY24 and a net profit of Rs 2917.54 crore, showing strong financial growth.
Now loading...
